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Abstract: Osteoarthritis (OA) affects the integrity of the entire joint including the synovium. The most
abundant cells in the synovium are fibroblasts (SF). Excessive mechanical loading might contribute to
OA pathogenesis. Here, we investigate the effects of mechanical loading on SF derived from non-OA
(N-SF) and OA patients (OA-SF). We treated N-SF and OA-SF with or without mechanical loading for
48h after 24h of preincubation. Then we assessed gene and protein expression of proinflammatory
factors (TNFα, COX-2, PG-E2, IL-6), extracellular matrix (ECM) components (COL1, FN1) and
glycosaminoglycans (GAGs) via RT-qPCR, ELISA, DMMB assay and HPLC. Mechanical loading
significantly increased TNFα and PG-E2 secretion by N-SF and OA-SF, whereas in OA-SF IL-6
secretion was reduced. COL1 and FN1 secretion were downregulated in N-SF during loading.
OA-SF secreted less COL1 compared to N-SF under control conditions. In contrast, OA-SF in
general expressed more FN1. GAG synthesis was upregulated in N-SF, but not in OA-SF during
loading with OA-SF displaying a higher charge density than N-SF. Mechanical loading enhanced
proinflammatory factor expression and GAG synthesis and decreased secretion of ECM components
in N-SFs, indicating a contributing role of SF to OA development.
Keywords: osteoarthritis; synovial fibroblasts; mechanical loading; synovium; inflammation; synovitis;
compressive force
1. Introduction
Osteoarthritis (OA) is the most common chronic degenerative joint disease [1] and is characterised
by subchondral bone remodelling, progressive cartilage degradation, chronic pain and synovitis [2].
The pathological phenotype arises from inflammatory processes and reorganizations in the cartilage,
the subchondral bone, the joint capsule and the synovial membrane [3]. Cartilage degradation and
bone resorption ultimately lead to loss of joint function. The pathomechanism of OA is based on
the primary destruction of extracellular matrix structures by mechanical failure and overload [4].
Articular cartilage is able to adapt to mechanical loading [5]. Moderate mechanical loading is
reported to reduce expression of proteolytic enzymes and to prevent progression of OA [5]. Animal
experiments showed that normal mechanical joint loading during moderate physical activity prevented
cartilage degradation compared to unexercised rats [6]. Furthermore, in vitro experiments using
mesenchymal stem cells revealed increased matrix deposition in response to mechanical loading [7].
Mechanical overloading, however, causes damage of the collagen network and promotes destruction of
Int. J. Mol. Sci. 2019, 20, 585; doi:10.3390/ijms20030585 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2019, 20, 585 2 of 12
the articular cartilage, therefore triggering OA progression [5]. If the load capacity of the tissue
is exceeded, a shift in the physiological balance of anabolic and catabolic processes occurs [4].
A restructuring of the cartilage matrix is already evident in early stages of the disease. The necessary
matrix components like proteoglycans are proteolytically degraded, and the process of cartilage
destruction begins. Chondrocytes activate catabolic enzymes [3], and the articular tissue reacts with
an inflammatory reaction of the synovial membrane (synovitis). Thus, OA affects not only cartilage
and subchondral bone, but also the integrity of the entire joint tissue, including the synovium. The
synovium is responsible for the maintenance of synovial fluid volume and composition, mainly
producing hyaluronic acid and lubricin, which helps to maintain and protect the integrity of articular
cartilage [8,9]. It is composed of immune cells and synovial fibroblasts (SF). Histologically, the synovial
membrane of OA joints exhibits hyperplasia of the lining cell layer and is accompanied by an infiltration
of immune cells like monocytes and lymphocytes [10]. SF represent the main cell population in healthy
synovium. They play a major mediating role in the development of OA, as they have immunological
functions and elicit an immunological response [11]. SF have been shown to express immune receptors
like toll-like receptors (TCR) [12,13]. In addition, SF were reported to produce proinflammatory
cytokines and RANK-L (receptor activator of NF-κB ligand), which promotes osteoclastogenesis
and therefore bone resorption [14]. There are several risk factors for developing an OA, such as
aging, obesity and mechanical overload [15], as excessive mechanical loading on normal articular
cartilage is generally supposed to initiate the disruption of cartilage matrix homeostasis, therefore
resulting in OA [4]. Currently, however, there is limited information whether and how mechanical
joint overload and consequent compressive deformation of SF also directly affect their expression
profile by mechanotransductive signalling, which could possibly constitute an important additional
pathomechanism of osteoarthritis. The aims of this study were thus to investigate the impact of static
compressive force application on SF derived from non-OA patients (N-SF) and OA-patients (OA-SF)
and to compare the effects between both groups.
2. Results
2.1. Impact of Mechanical Loading on the Expression of Proinflammatory Cytokines
First we focused on the expression of genes and proteins involved in proinflammatory processes.
In N-SF, gene and protein expression of tumour necrosis factor α (TNFα) was significantly upregulated
after pressure application, whereas in OA-SF, gene expression of TNFα was not significantly altered
(Figure 1a). However, an enhanced TNFα protein secretion in OA-SF was still detectable after
compressive force treatment, although this protein secretion was significantly lower than in N-SF
(Figure 1a). Gene expression of the proinflammatory gene cyclooxygenase-2 (COX-2) was evaluated in
N-SF and in OA-SF (Figure 1b) after mechanical loading. COX-2 mRNA was significantly reduced in
OA-SF under both tested conditions (Figure 1b). As COX-2 is responsible for prostaglandin-E2 (PG-E2)
expression, we investigated protein levels of PG-E2 in the supernatant of stimulated cells. We found
a significant induction of PG-E2 secretion in N-SF and OA-SF after compressive force application
(Figure 1b). There was a slight but significant reduction of PG-E2 in OA-SF compared to N-SF under
control conditions (Figure 1b). Next, we focused on the gene and protein expression of interleukin-6
(IL-6). Again, we found a significant induction of IL-6 gene expression and protein secretion in N-SF
(Figure 1c) with an analogous but reduced response by OA-SF.


















Figure 1. Impact of static compressive force application on the expression of proinflammatory genes.
Gene expression and protein secretion of (a) TNF-α, (b) COX-2/PG-E2 and (c) IL-6 of N-SF and
OA-SF after 48 h with or without static compressive force application. AU: arbitrary units; RT-qPCR:
n = 9; ELISA: n = 6. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤0.001. Statistics: Welch-corrected ANOVA with
Games-Howell post-hoc-tests.
2.2. Impact of Mechanical Loading on Extracellular Matrix Composition
We investigated genes that are involved in extracellular matrix formation and remodelling.
Collagen I (COL1) gene expression was significa tly enhanced after mechanical loading in N-SF, but
n t in OA-SF (Figure 2a). Surprisingly, we found reduced COL1 secretio into the supernatant of
N-SF after compressive force application. The supernatant of OA-SF already contained less COL1
under control conditi ns compared to N-SF (Figure 2a). Gene expression of fibronectin (FN1) was
significantly upregulated after pressure treatment in N-SF and in OA-SF (Figure 2b). Like COL1, FN1
protein secretion decreased after mechanical loadi g in N-SF a d OA-SF. OA-SF, however, secreted
significantly more FN1 into the supernatant under control and pressure conditions compared to N-SF
(Figure 2b).
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Figure 2. I pact of static co pressive force application on the extracellular atrix. Gene expression
and protein secretion of (a) COL1 and (b) FN1 of N-SF and OA-SF after 48 h with or without static
compressive force application. AU: arbitrary units; RT-qPCR: n = 9; ELISA: n = 6. * p ≤ 0.05, ** p ≤ 0.01,
*** p ≤ 0.001. Statistics: Welch-corrected ANOVA with Games-Howell post-hoc-tests.
2.3. Impact of Mechanical Loading on Glycosaminoglycan (GAG) Synthesis and Sulfatation
In addition to collagen, GAGs play an important role in the composition of the extracellular matrix.
We found enhanced gene expression of hyaluronan synthase 1 (HAS1) in N-SF, but not in OA-SF
after mechanical loading (Figure 3a). This was accompanied by enhanced chondroitin sulphate (CS)
content in N-SF after compressive force application (Figure 3b). OA-SF failed to react with enhanced
CS content to mechanical loading (Figure 3b). We detected increased charge density by HPLC in N-SF
after mechanical loading (Figure 3c). In OA-SF, we found a significantly increased charge density
under control conditions (Figure 3c).
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Figure 3. Impact of static compressive force application on glycosaminoglycans (GAG) synthesis.
(a) Gene expression of hyaluronan synthase 1 (HAS1) by N-SF and OA-SF after 48 h with or without
static compressive force application. (b) Chondroitin sulphate (CS)-content (DMMB assay) and
(c) charge density (HPLC) of GAGs of N-SF and OA-SF after 48 h with or without static compressive
force application. AU: arbitrary units; RT-qPCR: n = 9; DMMB: n = 9. * p≤ 0.05, ** p≤ 0.01, *** p ≤ 0.001.
Statistics: Welch-corrected ANOVA with Ga es-Howell post-hoc-tests.
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3. Discussion
In this study, we investigated the impact of mechanical loading on the expression profile of SF
derived from non-OA (N-SF) and from OA patients (OA-SF) and possible differences between these
conditions corresponding to pre-osteoarthritis (non-OA) and chronic osteoarthritic (OA) conditions.
In line with other studies, we demonstrated that mechanical loading on SF upregulated
proinflammatory cytokines like TNFα, PG-E2 and IL-6 [16]. TNFα is considered to be a key
proinflammatory cytokine during the pathological processes in the development of OA [3]. TNFα is
synthesised and secreted by chondrocytes, osteoblasts, mononuclear cells and synovial fibroblasts
during the inflammatory response [17–19]. TNFα is responsible for blocking the synthesis of
proteoglycan components and collagen by chondrocytes [20,21]. In our study, mechanical loading
resulted in an upregulation of TNFα protein expression in synovial fibroblasts derived from non-OA
and OA patients. Of note, the reaction of SF derived from OA patients to mechanical pressure was
significantly reduced. It would seem that mechanical compressive stimulation of synovial fibroblasts
is more important in the initial pathogenesis of OA, but of less or no importance in the maintenance
of (chronic) OA. In this phase of the disease, other cell types apart from synovial fibroblasts such as
immune cells, which accumulate in the synovium during OA due to chemokines secreted by SF [22],
could be of greater importance, which merits further investigation.
TNFα can trigger an enhanced synthesis of IL-6, COX-2 and PG-E2 [23–26]. Accordingly, we could
also show that the gene expression of COX-2, which is a key enzyme of PG-E2 synthesis, was increased
by mechanical loading in N-SF. PG-E2 plays an important role in OA by causing inflammation, cartilage
degradation and pain [27–29]. Mechanical loading also caused an increase in IL-6 gene expression
and protein secretion in N-SF, but not in OA-SF. IL-6 is a cytokine that enhances inflammatory
responses [30]. IL-6 expression causes a decrease in collagen production and an increase of matrix
metalloproteinase expression [31–34]. SF derived from OA patients failed to react to the mechanical
loading with enhanced IL-6 secretion, again indicating a disturbed reaction profile and hinting at a
reduced importance of synovial fibroblasts in the maintenance of proinflammatory processes during
osteoarthritis, in contrast to its onset.
Alterations of extracellular matrix (ECM) composition to an atypical configuration are common
in OA joints [35,36]. ECM breakdown products are suggested to promote inflammation and thereby
cartilage loss [37]. In our study, mechanical loading also showed an impact on extracellular matrix
composition, as it impaired COL1 and FN1 protein secretion by N-SF and OA-SF. This observation is
in line with reports that, in early stages of OA, collagen changes from type II to type I in the cartilage
of the knee joint [38]. This compositional change affects the elasticity and mechanical stability of the
ECM network [39]. Surprisingly, without mechanical loading, SF from OA-patients secreted less COL1,
but more FN1 protein than N-SF. A possible explanation could be the fact that FN1 fragments were
reported to induce the production of proinflammatory cytokines including TNFα [37,40], which could
promote and maintain the inflammatory reaction during OA.
Hyaluronic acid (HA) is synthesized by HA synthase 1 (HAS1) at the inner surface of the plasma
membrane [41]. It serves a variety of functions, including lubrication of joints [22]. Changes in the
serum concentration of HA are associated with inflammatory and degenerative arthropathies such as
rheumatoid arthritis [42,43]. In a murine model of knee joint cartilage damage, a deficiency of HAS1
triggered chronic joint inflammation and was associated with widespread intra-articular fibrosis [44].
Chondroitin sulphate is a sulphated heteropolysaccharide found in the cartilage and extracellular
matrix [45,46]. CS is negatively charged and reported to interact readily with extracellular matrix
proteins modulating cellular activities [47]. In this study, mechanical loading significantly increased
charge density, chondroitin sulphate (CS) content as well as gene expression of HAS1 in N-SF, but not
in OA-SF, again indicating an impaired responsiveness to mechanical loading in line with the previous
observations. CS are the most widely used drugs for the treatment of OA [48] and are reported to slow
down OA development [49]. The enhanced CS content measured in N-SF due to mechanical loading
may therefore provide a protection mechanism for the joint.
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Judging from these observations, it would seem that the combination of inflammation-induced
downregulation of ECM synthesis and proinflammatory effects of ECM-breakdown-components like
FN1 promotes OA onset and progression induced by mechanical loading.
4. Materials and Methods
4.1. In Vitro Cell Culture Experiment Setup
We obtained synovial fibroblasts either from non-OA patients (N-SF, n = 2; male and female;
age: 39 and 47) or from OA patients (OA-SF, n = 3, two females, one male; age: 67–76). N-SF
were ordered from BIOIVT (PCD-90-0645, West Sussex, UK). OA-SF were derived and cultivated
from excess tissue arising during knee surgery of patients with osteoarthritis in the Department of
Orthopedics of the University of Regensburg. Briefly, we released synovia from surrounding fat
and shred the tissue using a scalpel in a dish with 1 mL dispase I (D4818, Sigma-Aldrich, Munich,
Germany). We incubated tissue slices for 2 h in dispase I at 37 ◦C. Supernatant was put onto a 70 µm
cell strainer, dispase I removed by centrifugation and cells were grown in DMEM high glucose (D5796,
Sigma-Aldrich) supplemented with 10% FCS (P30-3306, PAN-Biotech, Aidenbach, Germany), 1%
L-glutamine (SH30034.01, GE Healthcare Europe, Munich, Germany), 100 µM ascorbic acid (A8960,
Sigma-Aldrich) and 1% antibiotics/antimycotics (A5955, Sigma-Aldrich). All synovial fibroblasts
were characterized according to their spindle-shaped morphology and the expression of fibroblast
specific genes. For our experiments, we seeded 60,000 synovial fibroblasts per well onto standard
6-well cell culture plates and preincubated the cells for 24h at standard cell culture conditions (37 ◦C,
5% CO2, 100% H2O) in DMEM high glucose, supplemented as already indicated above. To minimize
the risk of contamination, particularly with immune cells, we used fibroblasts not earlier than the
3rd passage [50]. Fibroblasts were then further incubated for another 48 h and either left untreated
(controls) or compressed with a pressure level of 2 g/cm2 by applying a sterile glass disc according to
an established and published model [51–54] (Figure 4) to simulate mechanical loading. After 72 h of
incubation, we harvested the cells and the cell culture supernatant for further analyses.
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4.2. RNA Isolation and RT-qPCR
We performed RNA isolation and quality assessment as well as RT-qPCR, as described before
according to MIQE (minimum information for publication of quantitative real-time PCR experiments)
guidelines [51]. Briefly, we extracted total RNA from synovial fibroblasts using 1 mL peqGOLD
TriFast™ (PEQLAB) per well, and further processing was conducted according to the manufacturer’s
instructions. We eluted the obtained RNA pellet in 20 µL nuclease-free water. As shown before, this
extraction protocol guarantees sufficient RNA integrity (RIN, 28S/18S ratio) as well as absence of
genomic DNA contamination [51]. We transcribed a standardized amount of RNA per sample by
using 0.5 µL of an oligo-dT18 primer (SO131, Thermo Fisher Scientific, Waltham, MA, USA), 0.5 µL
of a random hexamer primer (SO142, Thermo Fisher Scientific), 0.5 µL dNTP mix (L785.2, Carl Roth,
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Karlsruhe, Germany), 0.5 µL of an RNase inhibitor (EO0381, Thermo Fisher Scientific), 0.5 µL reverse
transcriptase (M1705, Promega, Madison, WI, USA) and 2 µL 5× M-MLV-buffer (M1705, Promega).
Nuclease-free H2O was added to a total volume of 10 µL for cDNA synthesis. We incubated this
reaction mixture for 60 min at 37 ◦C. After heat inactivation of reverse transcriptase (95 ◦C, 2 min),
we diluted cDNA 1:10 with nuclease-free H2O and stored it at −20 ◦C until use. cDNA synthesis was
performed for all samples at the same time to minimize experimental variation. RT-qPCR amplification
was performed with a Mastercycler® ep realplex-S thermocycler (Eppendorf, Hamburg, Germany),
as described before [51]. Each reaction mix contained 7.5 µL SYBR® Green JumpStart™ Taq ReadyMix™
(S4438; Sigma–Aldrich), 0.75 µL of the respective primer pair (3.75 pmol/primer) and 1.5 µL of the
respective cDNA dilution. Nuclease-free H2O was added to a total amount of 15 µL. We prepared
all components except the cDNA solution as a master-mix to avoid technical errors during manual
pipetting. cDNA amplification was performed in 45 cycles (initial heat activation 95 ◦C/5 min, per
cycle 95 ◦C/10 s denaturation, 60 ◦C/8 s annealing, 72 ◦C/8 s extension). We used a set of two
reference genes (EEF1A1 and RPLP0) for normalization of target genes (relative gene expression),
which have been tested and shown to be stably expressed in synovial fibroblasts under the investigated
conditions (data not shown). Relative gene expression was calculated as 2-∆Cq [55]. We constructed
all intron-flanking, gene-specific primers (Table 1) according to MIQE quality guidelines and criteria
as described before [51].




















COL1 collagen, type I, α2 NM_000089.3 AGAAACACGTCTGGCTAGGAG GCATGAAGGCAAGTTGGGTAG
FN1 fibronectin 1 NM_212482.1 GCCAGTCCTACAACCAGTATTCTC GCTTGTTCCTCTGGATTGGAAAG
HAS1 hyaluronansynthase 1 NM_001523.3 GAGCCTCTTCGCGTACCTG CCTCCTGGTAGGCGGAGAT






TNFα Tumor necrosefactor α NM_000594.3 GAGGCCAAGCCCTGGTATG CGGGCCGATTGATCTCAGC
4.3. ELISA Assays
For quantification of tumour necrosis factor α (TNFα) and prostaglandin E2 (PGE2), interleukin-6
(IL-6), collagen-1 (COL-1) and fibronectin (FN-1) protein secretion into the synovial fibroblast
supernatant, we used commercially available ELISA kits according to the manufacturers’ instructions
(TNFα: EK0525, Boster Biological Technology; PGE2: 514010; Cayman chemical; IL-6: EK0410 Boster
Biological Technology; COL-1: ab210966, Abcam; FN-1: EK0349, Boster Biological Technology). Protein
expression per well was related to the respective number of synovial fibroblasts, counted with a
Beckman Coulter Counter (Z2 cell counter).
4.4. Isolation of Glycosaminoglycans (GAGs)
Approximately 1.5 mL cell culture supernatant was freeze-dried at the end of incubation. After
reconstitution of the pellet in 300 µL H2O, we added 900 µL ethanol and incubated at−20 ◦C overnight.
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Samples were then centrifuged for 5 min at 5000 rpm, and the resulting pellet was solved in 300 µL
0.1 M NH4Ac. Samples were incubated with 20 U/mL proteinase K (Sigma-Aldrich) for 2 h at 55 ◦C.
After heat inactivation (5 min, 100 ◦C), we added 900 µL ethanol and incubated overnight at −20 ◦C.
After centrifugation for 5 min at 5000 rpm, the pellet was reconstituted in 50 µL H2O and used for
further analyses (DMMB and HPLC).
4.5. Determination of Chondroitin Sulphate Content via DMMB Assay
DMMB (dimethylenmethylblue, Sigma-Aldrich) specifically stains chondroitin sulphate. Ten
microlitres of the respective eluted GAG sample or of a standard dilution series (1:10) of known
concentrations of chondroitin sulphate A (Sigma-Aldrich), used for calibration, were mixed with
190 µL DMMB staining solution (10 mL 2 M NaCl, 1.5 g glycine solved in 490 mL H2O, pH 3.0 adjusted
with HCl; 8 mg DMMB solved in 2.5 mL ethanol and added) and measured in an ELISA-reader
(Multiscan Go, Thermo Fisher Scientific) at 520 nm. All measurements were performed in triplets.
4.6. HPLC Analysis
We treated 10 µL of the GAG samples with 5 mU of chondroitin ABC lyase (Sigma-Aldrich) and
incubated them in 50 µL of 100 mM Tris / 150 mM sodium acetate buffer (pH 8.0) at 37 ◦C for 16 h.
The reaction was blocked by boiling the solution for 1 min. We analysed the unsaturated disaccharides
generated from hyaluronic acid (HA) and chondroitin sulphate (CS) after enzymatic treatment of the
purified GAGs by strong anion exchange HPLC separation at 232 nm (column: Sphere-Image 80-5
SAX, Knauer, Berlin, Germany; equipment: Shimazdu, Duisburg, Germany, consisting of degasifier
DGU-20A3, two pumps LC-20AT, autosampler SIL-20A, controller CBM-20A, detector SPD-20A;
software: LCSolution). Isocratic separation was performed for 15 min with 10 mM NaH2PO4, pH 4.0
and afterwards linear gradient separation for another 20 min with 10 mM NaH2PO4, pH 4.0 to 33%
750 mM NaH2PO4, pH 4.0. Flow rate was 1.2 mL/min. Charge density was calculated by dividing the
area under the curve (AUC) for CS by the AUC for (HA+CS).
4.7. Statistical Analysis
To obtain normalized data values we divided all absolute data by the respective arithmetic mean
of the pressure-untreated N-SF controls prior to statistical analysis. All data were tested for normal
distribution (Shapiro-Wilk test) and homogeneity of variance (Levene’s test) using the software SPSS®
Statistics 24 (IBM®, Armonk, NY, USA). Descriptive statistics are given as mean ± standard deviation.
The experimental groups were independently compared by one-way ANOVAs, which were validated
by applying Welch’s test, since homogeneity of variance not always present. For the same reason,
we used Games–Howell post hoc tests for heterogeneous variances for pairwise comparisons. All
differences were considered statistically significant at p ≤ 0.05.
5. Conclusions
In our study, SF react to mechanical loading with enhanced expression and secretion of
proinflammatory cytokines and changes of ECM composition. These changes might contribute to OA
pathogenesis and progression. SF derived from OA patients seem to be less responsive to mechanical
loading, indicating a more important role of SF in OA onset than in OA maintenance, which might
be predominantly mediated by cells of the immune system. Moreover, it should be noted that OA
pathogenesis and progression are complex and multicellular processes; thus, the results derived from
SF need to be corroborated for other OA-relevant cell types such as immune cells in future experiments.
Furthermore, different mechanical loading protocols might elucidate the role of SF in catabolic and
anabolic events during OA.
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